Unilateral vs Bilateral Total Hip Arthroplasty

The purpose of the present study was to determine whether unilaterally operated total hip arthroplasty (THA) patients were superior to bilaterally operated THA patients with respect to aerobic endurance capacity, muscle strength and gait patterns 3-5 years after surgery, and to what extent medial femoral head offset (FO) influenced hip abductor strength.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteoarthritis, Hip Arthritis Joint Diseases Musculoskeletal Diseases Osteoarthritis Rheumatic Diseases

Age range

40 year–70 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Undergone hip surgery 3-5 years ago
Age < 70 years

Exclusion criteria

Heart or lung diseases
Malign diseases
No muscle/skeletal diseases that compromises testing

Treatment and study plan

total hip arthroplasty one side

Procedure

unilateral total hip arthroplasty

total hip arthroplasty both sides

Procedure

bilateral total hip arthroplasty

Sponsors and collaborators

Lead sponsor

Norwegian University of Science and Technology

Other

Collaborators

OrtoMedic A/S, Oslo
Scandinavian Customized Prosthesis (SCP)

Registry information

Official study title

Unilateral vs Bilateral Total Hip Arthroplasty - the Influence of Medial Femoral Head Offset and Effects on Strength and Aerobic Endurance Capacity

Important dates

Study start: 2007
Primary completion: 2009
Study completion: 2009
First posted: Oct 2, 2008
Registry last updated: Mar 20, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed